CA Stock MarketDetailed Quotes

Pharmadrug Inc (PHRX)

Watchlist
  • 0.005
  • -0.005-50.00%
15min DelayMarket Closed Jun 1 09:53 ET
671.07KMarket Cap-1.25P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pharmadrug Inc (PHRX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
88.43%-87.51K
723.83%11.41K
-18.36%-11.23K
64.45%-72.8K
97.26%-14.89K
-12.61%-756.62K
100.48%1.39K
94.03%-9.49K
-57.49%-204.77K
-489.36%-543.75K
Net income from continuing operations
50.47%-432.51K
-1,939.24%-143.42K
51.84%-87.16K
41.08%-84.85K
78.36%-117.08K
93.42%-873.16K
99.94%-7.03K
39.68%-180.96K
65.71%-144.02K
-202.70%-541.15K
Operating gains losses
-420.96%-116.9K
---118.3K
--0
----
----
-77.33%36.42K
----
----
----
----
Depreciation and amortization
0.00%50.24K
0.00%12.56K
0.00%12.56K
0.00%12.56K
0.00%12.56K
91.65%50.24K
-52.09%12.56K
--12.56K
--12.56K
--12.56K
Asset impairment expenditure
----
----
----
----
----
--0
----
----
----
----
Unrealized gains and losses of investment securities
--0
----
----
----
----
109.76%11.94K
--0
-48.42%11.94K
--0
--0
Remuneration paid in stock
--0
--0
--0
----
----
-97.29%47.23K
--0
--0
--47.23K
----
Deferred tax
----
----
----
----
----
--0
----
----
----
----
Other non cashItems
13.30%310.29K
1,203.97%146.6K
-49.97%56.3K
-33.72%54.45K
-42.75%52.93K
-28.74%273.87K
-107.38%-13.28K
318.46%112.53K
-8.69%82.16K
5.77%92.46K
Change In working capital
133.44%101.37K
517.69%113.97K
-79.49%7.06K
72.20%-56.36K
134.09%36.69K
-203.11%-303.18K
-241.55%-27.29K
-17.98%34.44K
-254.52%-202.7K
-205.95%-107.63K
-Change in receivables
334.41%9.05K
168.54%4.43K
-105.99%-2.66K
-235.58%-6.57K
129.67%13.85K
-202.30%-3.86K
58.52%-6.47K
363.85%44.43K
225.38%4.84K
-441.78%-46.67K
-Change in prepaid assets
260.00%13.33K
--0
--0
110.00%5K
--8.33K
-196.04%-8.33K
933.34%41.67K
--0
-1,196.49%-50K
--0
-Change in payables and accrued expense
127.14%78.98K
275.31%109.54K
197.36%9.73K
65.22%-54.8K
123.80%14.51K
-182.76%-290.98K
-156.87%-62.49K
-135.86%-9.99K
-220.74%-157.54K
-173.12%-60.96K
Cash from discontinued investing activities
Operating cash flow
88.43%-87.51K
723.90%11.41K
-18.37%-11.23K
64.45%-72.8K
97.26%-14.89K
-12.61%-756.62K
100.48%1.39K
94.03%-9.49K
-57.49%-204.77K
-489.36%-543.75K
Investing cash flow
Cash flow from continuing investing activities
0
-101.20%-11.98K
-101.62%-11.98K
0
0
0
Net intangibles purchas and sale
--0
----
----
----
----
---11.98K
----
----
----
----
Net business purchase and sale
----
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
----
----
----
----
----
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
----
----
----
----
-101.20%-11.98K
-101.62%-11.98K
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
0
0
0
0
0
42.59%321.56K
91.32%-4.44K
0
0
379.73%326K
Net issuance payments of debt
----
----
----
----
----
--0
--0
--0
--0
--0
Net common stock issuance
--0
--0
--0
--0
--0
--326K
--0
--0
--0
--326K
Cash dividends paid
----
----
----
----
----
--0
--0
--0
--0
--0
Interest paid (cash flow from financing activities)
----
----
----
----
----
--0
--0
--0
--0
--0
Net other financing activities
----
----
----
----
----
-101.48%-4.44K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
--0
--0
--0
--0
42.59%321.56K
91.32%-4.44K
--0
--0
379.73%326K
Net cash flow
Beginning cash position
-80.23%110.76K
-90.76%11.83K
-83.24%23.06K
-72.00%95.86K
-80.23%110.76K
6,562.65%560.13K
-19.97%128.12K
1,286.75%137.61K
3,994.93%342.38K
6,447.39%560.13K
Current changes in cash
80.42%-87.51K
175.93%11.41K
-18.37%-11.23K
64.45%-72.8K
93.16%-14.89K
-181.48%-447.04K
-103.76%-15.03K
-106.36%-9.49K
-21,408.01%-204.77K
-24,644.55%-217.75K
Effect of exchange rate changes
--0
----
----
----
----
-176.51%-2.34K
-402.07%-2.34K
--0
--0
--0
End cash Position
-79.01%23.24K
-79.01%23.24K
-90.76%11.83K
-83.24%23.06K
-72.00%95.86K
-80.23%110.76K
-80.23%110.76K
-19.97%128.12K
1,286.75%137.61K
3,994.93%342.38K
Free cash from
88.61%-87.51K
207.74%11.41K
-18.37%-11.23K
64.45%-72.8K
97.26%-14.89K
-14.40%-768.6K
96.36%-10.59K
94.03%-9.49K
-57.49%-204.77K
-489.36%-543.75K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 88.43%-87.51K723.83%11.41K-18.36%-11.23K64.45%-72.8K97.26%-14.89K-12.61%-756.62K100.48%1.39K94.03%-9.49K-57.49%-204.77K-489.36%-543.75K
Net income from continuing operations 50.47%-432.51K-1,939.24%-143.42K51.84%-87.16K41.08%-84.85K78.36%-117.08K93.42%-873.16K99.94%-7.03K39.68%-180.96K65.71%-144.02K-202.70%-541.15K
Operating gains losses -420.96%-116.9K---118.3K--0---------77.33%36.42K----------------
Depreciation and amortization 0.00%50.24K0.00%12.56K0.00%12.56K0.00%12.56K0.00%12.56K91.65%50.24K-52.09%12.56K--12.56K--12.56K--12.56K
Asset impairment expenditure ----------------------0----------------
Unrealized gains and losses of investment securities --0----------------109.76%11.94K--0-48.42%11.94K--0--0
Remuneration paid in stock --0--0--0---------97.29%47.23K--0--0--47.23K----
Deferred tax ----------------------0----------------
Other non cashItems 13.30%310.29K1,203.97%146.6K-49.97%56.3K-33.72%54.45K-42.75%52.93K-28.74%273.87K-107.38%-13.28K318.46%112.53K-8.69%82.16K5.77%92.46K
Change In working capital 133.44%101.37K517.69%113.97K-79.49%7.06K72.20%-56.36K134.09%36.69K-203.11%-303.18K-241.55%-27.29K-17.98%34.44K-254.52%-202.7K-205.95%-107.63K
-Change in receivables 334.41%9.05K168.54%4.43K-105.99%-2.66K-235.58%-6.57K129.67%13.85K-202.30%-3.86K58.52%-6.47K363.85%44.43K225.38%4.84K-441.78%-46.67K
-Change in prepaid assets 260.00%13.33K--0--0110.00%5K--8.33K-196.04%-8.33K933.34%41.67K--0-1,196.49%-50K--0
-Change in payables and accrued expense 127.14%78.98K275.31%109.54K197.36%9.73K65.22%-54.8K123.80%14.51K-182.76%-290.98K-156.87%-62.49K-135.86%-9.99K-220.74%-157.54K-173.12%-60.96K
Cash from discontinued investing activities
Operating cash flow 88.43%-87.51K723.90%11.41K-18.37%-11.23K64.45%-72.8K97.26%-14.89K-12.61%-756.62K100.48%1.39K94.03%-9.49K-57.49%-204.77K-489.36%-543.75K
Investing cash flow
Cash flow from continuing investing activities 0-101.20%-11.98K-101.62%-11.98K000
Net intangibles purchas and sale --0-------------------11.98K----------------
Net business purchase and sale ----------------------0----------------
Net investment purchase and sale ----------------------0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow --0-----------------101.20%-11.98K-101.62%-11.98K--0--0--0
Financing cash flow
Cash flow from continuing financing activities 0000042.59%321.56K91.32%-4.44K00379.73%326K
Net issuance payments of debt ----------------------0--0--0--0--0
Net common stock issuance --0--0--0--0--0--326K--0--0--0--326K
Cash dividends paid ----------------------0--0--0--0--0
Interest paid (cash flow from financing activities) ----------------------0--0--0--0--0
Net other financing activities ---------------------101.48%-4.44K----------------
Cash from discontinued financing activities
Financing cash flow --0--0--0--0--042.59%321.56K91.32%-4.44K--0--0379.73%326K
Net cash flow
Beginning cash position -80.23%110.76K-90.76%11.83K-83.24%23.06K-72.00%95.86K-80.23%110.76K6,562.65%560.13K-19.97%128.12K1,286.75%137.61K3,994.93%342.38K6,447.39%560.13K
Current changes in cash 80.42%-87.51K175.93%11.41K-18.37%-11.23K64.45%-72.8K93.16%-14.89K-181.48%-447.04K-103.76%-15.03K-106.36%-9.49K-21,408.01%-204.77K-24,644.55%-217.75K
Effect of exchange rate changes --0-----------------176.51%-2.34K-402.07%-2.34K--0--0--0
End cash Position -79.01%23.24K-79.01%23.24K-90.76%11.83K-83.24%23.06K-72.00%95.86K-80.23%110.76K-80.23%110.76K-19.97%128.12K1,286.75%137.61K3,994.93%342.38K
Free cash from 88.61%-87.51K207.74%11.41K-18.37%-11.23K64.45%-72.8K97.26%-14.89K-14.40%-768.6K96.36%-10.59K94.03%-9.49K-57.49%-204.77K-489.36%-543.75K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 0.00%
Sample Name
Sample Code
 -3.01%
Sample Name
Sample Code
 -4.40%
4
SINOPEC CORP
00386
-4.98%
5
PETROCHINA
00857
-8.12%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +18.61%
Sample Name
Sample Code
 +16.66%
Sample Name
Sample Code
 +7.51%
4
Business-intelligence Of Oriental Nations Corporation
300166
+5.05%
5
Iflytek Co.,ltd.
002230
+0.98%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 1 Eastern Time, Middle East geopolitics took a dramatic turn. Iran's Tasnim News Agency reported that, in light of Israel’s ongoing Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -